Sudhir Sinha

Employment

• Sanjay Gandhi Post Graduate Institute of Medical Sciences Emeritus Scientist
  2016 - Present
• CSIR-Central Drug Research Institute Scientist
  1991 - 2015
• National JALMA Institute of Leprosy and other Mycobacterial Diseases Scientist
  1978 - 1991

Education

• CSIR-Central Drug Research Institute (affiliated to Kanpur University) Ph.D.
  1983 - 1988
• University of Lucknow M.Sc.
  1974 - 1976

Projects & Funding

Projects & funding information is unavailable.

Publications (144)

• Styrene Maleic Acid Lipid Particles Prepared from Mycobacterium tuberculosis Plasma Membrane can Potentially Induce Innate and Adaptive Immune Responses in Healthy Individuals of a Tuberculosis Hyperendemic Region
  Current Microbiology 2026 DOI: 10.1007/s00284-026-05097-5
  +Save
• Antibodies to type I and type III interferons at diagnosis predispose to serious infections on follow-up in an inception cohort of SLE (INSPIRE) from India
  Arthritis and Rheumatology 2025 DOI: 10.1002/art.43421
  +Save
• Relevance of antigen‐induced IL‐6 and mitogen‐induced or spontaneous IFN‐γ secretions in whole blood cultures for detection of Mycobacterium tuberculosis infection and disease
  Scandinavian Journal of Immunology 2024 DOI: 10.1111/sji.13406
  +Save
• Immunochemical characterisation of styrene maleic acid lipid particles prepared from Mycobacterium tuberculosis plasma membrane
  PLOS ONE 2023 DOI: 10.1371/journal.pone.0280074
  +Save
• Distinct and shared B cell responses of tuberculosis patients and their household contacts
  PLOS ONE 2022 DOI: 10.1371/journal.pone.0276610
  +Save
• Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection
  PLOS ONE 2021 DOI: 10.1371/journal.pone.0255639
  +Save
• Immune responses to Mycobacterium tuberculosis membrane-associated antigens including alpha crystallin can potentially discriminate between latent infection and active tuberculosis disease
  PLOS ONE 2020 DOI: 10.1371/journal.pone.0228359
  +Save
• Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting
  PLOS ONE 2018 DOI: 10.1371/journal.pone.0204429
  +Save
• MANTOUX TEST IS INADEQUATE TO DEFINE ALL SUBJECTS WITH LATENT TUBERCULAR INFECTION
  Annals of the Rheumatic Diseases 2018 DOI: 10.1136/ANNRHEUMDIS-2018-EULAR.6919
  +Save
• Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
  ACS Omega 2017 DOI: 10.1021/acsomega.7b01966
  +Save